Christopher R. Cline

Chief Financial Officer, Travere Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$4.6M

Companies

Latest trade

Sep 15, 2026

Companies

Travere Therapeutics, Inc.Chief Financial Officer −$4.6M

Trades

TVTX Sold 50,508 shares at $62.34 · planned $3.1M Sep 15

TVTX Sold 642 shares at $66.37 $0.0M Sep 2

TVTX Sold 310 shares at $43.95 · planned $0.0M May 6

TVTX Sold 2,181 shares at $46.65 · planned $0.1M May 5

TVTX Sold 1,014 shares at $42.61 · planned $0.0M Apr 15

TVTX Sold 7,248 shares at $41.93 · planned $0.3M Apr 14

TVTX Sold 65 shares at $28.85 · planned $0.0M Apr 13

TVTX Sold 1,745 shares at $32.19 · planned $0.1M Feb 4

TVTX Sold 7,242 shares at $32.12 $0.2M Feb 3

TVTX Sold 20,000 shares at $35.01 · planned $0.7M Dec 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.